Dr. James Spicer is a Professor of Experimental Cancer Medicine at the King’s College in London funded by Cancer Research UK and National Institute for Health Research. He also serves as an Honorary Consultant in Medical Oncology at Guy’s and St. Thomas’ Hospitals NHS Foundation Trust UK. Professor Spicer trained at major London teaching hospitals, has a Ph.D. in cancer biology from the Institute of Cancer Research in London, and a degree in biochemistry from the University of Oxford. Professor Spicer’s interests include the development of new cancer drugs and the care of patients with thoracic malignancies, including lung cancer and mesothelioma. His research interests include early phase trials and novel immunotherapies.